ADVFN US – Market Content Editor
-
Cruise line shares slide amid rising concerns over promotional activity
Shares of major cruise operators dropped on Friday as investors reacted to growing signs of increased promotional efforts across the sector. Carnival Corporation (NYSE:CCL) led the decline with a 3.2% fall, while Royal Caribbean Cruises (NYSE:RCL) lost 2.7%, Norwegian Cruise Line Holdings (NYSE:NCLH) fell 1.7%, and Viking Holdings (NYSE:VIK) slid 2.5%. The selloff comes after…
-
WeRide shares climb after obtaining Belgium’s first Level 4 autonomous shuttle permit
WeRide Corp ADR (NASDAQ:WRD) saw its stock rise 3.7% in premarket trading Friday after the autonomous vehicle company revealed that its Robobus has received Belgium’s first federal test permit for a Level 4 autonomous shuttle. The permit authorizes the Robobus to conduct tests on public roads along an 8-kilometer loop in Leuven-Heverlee, featuring nine stops.…
-
22nd Century Group shares surge after clearing remaining debt
22nd Century Group Inc (NASDAQ:XXII) saw its stock jump 14.8% in premarket trading Friday after the company confirmed it has fully repaid the remaining $3.9 million of senior secured debt. The repayment follows the completion of the company’s Series A convertible preferred stock offering, which helped eliminate one of the final legacy obligations from its…
-
Chijet Motor shares surge after naming COO to head crypto initiative
Chijet Motor Company, Inc. (NASDAQ:CJET) saw its stock jump 80% in premarket trading Friday after announcing the appointment of Jason Miller as Chief Operating Officer, tasked with leading the company’s expansion into digital currencies. Miller will oversee Chijet’s strategy to integrate leading cryptocurrencies, including Bitcoin, Ethereum, and Solana, into the company’s treasury. With more than…
-
Fathom Holdings shares drop sharply after public offering priced
Fathom Holdings Inc (NASDAQ:FTHM) saw its stock fall 14.6% in premarket trading Friday following the announcement of an underwritten public offering. The company plans to sell 3 million shares of common stock at $2.00 per share. Fathom expects to raise approximately $5.4 million in net proceeds after underwriting fees and expected expenses. The underwriter, Roth…
-
Reviva Pharmaceuticals shares tumble after $9M public offering priced
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) saw its stock dive 39% in premarket trading Friday, following the announcement of a public offering intended to raise roughly $9 million. The company plans to offer 27 million shares of common stock, or equivalents, at $0.335 per share, each paired with one Series E and one Series F warrant,…
-
Dow Jones, S&P, Nasdaq, Wall Street Futures Signal Slight Gains Ahead
U.S. stock futures suggest a modestly higher open on Friday, as investors look to continue the momentum from Thursday’s strong session. Despite September typically being one of the weaker months for equities, major indexes have trended upward over the past few weeks. Optimism surrounding lower interest rates has bolstered the markets, following the Federal Reserve’s…
-
ARS Pharmaceuticals stock rises after Japan approves needle-free epinephrine spray
Shares of ARS Pharmaceuticals Inc. (NASDAQ:SPRY) climbed 7% on Friday following regulatory approval in Japan for the company’s needle-free epinephrine nasal spray, neffy, intended for emergency treatment of severe allergic reactions. Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) authorized neffy in 1 mg and 2 mg doses for adults and children over 15 kilograms, making…
-
Blackstone names Katie Keenan as new Breit CEO after LePatner’s death – WSJ
Blackstone (NYSE:BX) has selected Katie Keenan to lead Breit, one of the firm’s largest funds aimed at individual investors, following the untimely passing of former CEO Wesley LePatner, the Wall Street Journal reported. Keenan, 41, will additionally serve as the global head of Core+ real estate, managing all lower-risk investments across Blackstone’s $325 billion property…
-
Verrica Pharmaceuticals stock jumps on Japan approves YCANTH
Shares of Verrica Pharmaceuticals (NASDAQ:VRCA) jumped 27% on Friday after the biotech said its partner Torii Pharmaceutical secured marketing authorization in Japan for YCANTH (TO-208), a treatment for Molluscum Contagiosum. The green light from Japan’s Ministry of Health, Labour and Welfare also unlocks a $10 million milestone payment to Verrica. The company said it expects…